Global Pet Arthritis Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR072504958

Publication Date:

July 8, 2025

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Pet Arthritis market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The increasing companion animal population, growing prevalence of arthritis, rising risk factors for the disease, supportive awareness programs initiated by governments, and strategies implemented by key companies are some of the key factors driving the market.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly 鈧�6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 39%.
This report is a detailed and comprehensive analysis for global Pet Arthritis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pet Arthritis market size and forecasts, in consumption value ($ Million), 2020-2031
Global Pet Arthritis market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Pet Arthritis market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Pet Arthritis market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pet Arthritis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pet Arthritis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Virbac, Elanco, Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC., Vetoquinol, NexGen Pharmaceuticals, Norbrook, Eltech K-Laser s.r.l., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Pet Arthritis market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Osteoarthritis
Other Arthritis
Market segment by Application
Dogs
Cats
Others
Market segment by players, this report covers
Zoetis
Virbac
Elanco
Boehringer Ingelheim International GmbH
Ceva
Dechra Pharmaceuticals PLC.
Vetoquinol
NexGen Pharmaceuticals
Norbrook
Eltech K-Laser s.r.l.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pet Arthritis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pet Arthritis, with revenue, gross margin, and global market share of Pet Arthritis from 2020 to 2025.
Chapter 3, the Pet Arthritis competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Pet Arthritis market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pet Arthritis.
Chapter 13, to describe Pet Arthritis research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Pet Arthritis by Type
1.3.1 Overview: Global Pet Arthritis Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Pet Arthritis Consumption Value Market Share by Type in 2024
1.3.3 Osteoarthritis
1.3.4 Other Arthritis
1.4 Global Pet Arthritis Market by Application
1.4.1 Overview: Global Pet Arthritis Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Dogs
1.4.3 Cats
1.4.4 Others
1.5 Global Pet Arthritis Market Size & Forecast
1.6 Global Pet Arthritis Market Size and Forecast by Region
1.6.1 Global Pet Arthritis Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Pet Arthritis Market Size by Region, (2020-2031)
1.6.3 North America Pet Arthritis Market Size and Prospect (2020-2031)
1.6.4 Europe Pet Arthritis Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Pet Arthritis Market Size and Prospect (2020-2031)
1.6.6 South America Pet Arthritis Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Pet Arthritis Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 Zoetis
2.1.1 Zoetis Details
2.1.2 Zoetis Major Business
2.1.3 Zoetis Pet Arthritis Product and Solutions
2.1.4 Zoetis Pet Arthritis Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Zoetis Recent Developments and Future Plans
2.2 Virbac
2.2.1 Virbac Details
2.2.2 Virbac Major Business
2.2.3 Virbac Pet Arthritis Product and Solutions
2.2.4 Virbac Pet Arthritis Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Virbac Recent Developments and Future Plans
2.3 Elanco
2.3.1 Elanco Details
2.3.2 Elanco Major Business
2.3.3 Elanco Pet Arthritis Product and Solutions
2.3.4 Elanco Pet Arthritis Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Elanco Recent Developments and Future Plans
2.4 Boehringer Ingelheim International GmbH
2.4.1 Boehringer Ingelheim International GmbH Details
2.4.2 Boehringer Ingelheim International GmbH Major Business
2.4.3 Boehringer Ingelheim International GmbH Pet Arthritis Product and Solutions
2.4.4 Boehringer Ingelheim International GmbH Pet Arthritis Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Boehringer Ingelheim International GmbH Recent Developments and Future Plans
2.5 Ceva
2.5.1 Ceva Details
2.5.2 Ceva Major Business
2.5.3 Ceva Pet Arthritis Product and Solutions
2.5.4 Ceva Pet Arthritis Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Ceva Recent Developments and Future Plans
2.6 Dechra Pharmaceuticals PLC.
2.6.1 Dechra Pharmaceuticals PLC. Details
2.6.2 Dechra Pharmaceuticals PLC. Major Business
2.6.3 Dechra Pharmaceuticals PLC. Pet Arthritis Product and Solutions
2.6.4 Dechra Pharmaceuticals PLC. Pet Arthritis Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Dechra Pharmaceuticals PLC. Recent Developments and Future Plans
2.7 Vetoquinol
2.7.1 Vetoquinol Details
2.7.2 Vetoquinol Major Business
2.7.3 Vetoquinol Pet Arthritis Product and Solutions
2.7.4 Vetoquinol Pet Arthritis Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Vetoquinol Recent Developments and Future Plans
2.8 NexGen Pharmaceuticals
2.8.1 NexGen Pharmaceuticals Details
2.8.2 NexGen Pharmaceuticals Major Business
2.8.3 NexGen Pharmaceuticals Pet Arthritis Product and Solutions
2.8.4 NexGen Pharmaceuticals Pet Arthritis Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 NexGen Pharmaceuticals Recent Developments and Future Plans
2.9 Norbrook
2.9.1 Norbrook Details
2.9.2 Norbrook Major Business
2.9.3 Norbrook Pet Arthritis Product and Solutions
2.9.4 Norbrook Pet Arthritis Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Norbrook Recent Developments and Future Plans
2.10 Eltech K-Laser s.r.l.
2.10.1 Eltech K-Laser s.r.l. Details
2.10.2 Eltech K-Laser s.r.l. Major Business
2.10.3 Eltech K-Laser s.r.l. Pet Arthritis Product and Solutions
2.10.4 Eltech K-Laser s.r.l. Pet Arthritis Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Eltech K-Laser s.r.l. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Pet Arthritis Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Pet Arthritis by Company Revenue
3.2.2 Top 3 Pet Arthritis Players Market Share in 2024
3.2.3 Top 6 Pet Arthritis Players Market Share in 2024
3.3 Pet Arthritis Market: Overall Company Footprint Analysis
3.3.1 Pet Arthritis Market: Region Footprint
3.3.2 Pet Arthritis Market: Company Product Type Footprint
3.3.3 Pet Arthritis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Pet Arthritis Consumption Value and Market Share by Type (2020-2025)
4.2 Global Pet Arthritis Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Pet Arthritis Consumption Value Market Share by Application (2020-2025)
5.2 Global Pet Arthritis Market Forecast by Application (2026-2031)
6 North America
6.1 North America Pet Arthritis Consumption Value by Type (2020-2031)
6.2 North America Pet Arthritis Market Size by Application (2020-2031)
6.3 North America Pet Arthritis Market Size by Country
6.3.1 North America Pet Arthritis Consumption Value by Country (2020-2031)
6.3.2 United States Pet Arthritis Market Size and Forecast (2020-2031)
6.3.3 Canada Pet Arthritis Market Size and Forecast (2020-2031)
6.3.4 Mexico Pet Arthritis Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Pet Arthritis Consumption Value by Type (2020-2031)
7.2 Europe Pet Arthritis Consumption Value by Application (2020-2031)
7.3 Europe Pet Arthritis Market Size by Country
7.3.1 Europe Pet Arthritis Consumption Value by Country (2020-2031)
7.3.2 Germany Pet Arthritis Market Size and Forecast (2020-2031)
7.3.3 France Pet Arthritis Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Pet Arthritis Market Size and Forecast (2020-2031)
7.3.5 Russia Pet Arthritis Market Size and Forecast (2020-2031)
7.3.6 Italy Pet Arthritis Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Pet Arthritis Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Pet Arthritis Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Pet Arthritis Market Size by Region
8.3.1 Asia-Pacific Pet Arthritis Consumption Value by Region (2020-2031)
8.3.2 China Pet Arthritis Market Size and Forecast (2020-2031)
8.3.3 Japan Pet Arthritis Market Size and Forecast (2020-2031)
8.3.4 South Korea Pet Arthritis Market Size and Forecast (2020-2031)
8.3.5 India Pet Arthritis Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Pet Arthritis Market Size and Forecast (2020-2031)
8.3.7 Australia Pet Arthritis Market Size and Forecast (2020-2031)
9 South America
9.1 South America Pet Arthritis Consumption Value by Type (2020-2031)
9.2 South America Pet Arthritis Consumption Value by Application (2020-2031)
9.3 South America Pet Arthritis Market Size by Country
9.3.1 South America Pet Arthritis Consumption Value by Country (2020-2031)
9.3.2 Brazil Pet Arthritis Market Size and Forecast (2020-2031)
9.3.3 Argentina Pet Arthritis Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Pet Arthritis Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Pet Arthritis Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Pet Arthritis Market Size by Country
10.3.1 Middle East & Africa Pet Arthritis Consumption Value by Country (2020-2031)
10.3.2 Turkey Pet Arthritis Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Pet Arthritis Market Size and Forecast (2020-2031)
10.3.4 UAE Pet Arthritis Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Pet Arthritis Market Drivers
11.2 Pet Arthritis Market Restraints
11.3 Pet Arthritis Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Pet Arthritis Industry Chain
12.2 Pet Arthritis Upstream Analysis
12.3 Pet Arthritis Midstream Analysis
12.4 Pet Arthritis Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Zoetis
Virbac
Elanco
Boehringer Ingelheim International GmbH
Ceva
Dechra Pharmaceuticals PLC.
Vetoquinol
NexGen Pharmaceuticals
Norbrook
Eltech K-Laser s.r.l.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂